Analyzed findings found that LY6K is higher in ovarian cancer tissues relative to normal controls (Fig. 6B) and is more pronounced in recurring ovarian cancer tissues compared to cancer tissues (Fig. 6C). This evidence concerns the gene LY6K and ovarian carcinoma.